Protects from an “embarrassing disease”.. A therapeutic technique that brings medical good news to women

News" British, the researchers said Hormone therapy alternative or otherwise known as "hrt"is associated with better memory and cognitive function and larger brain size later in life in women who carry a gene considered to be the strongest risk factor for disease Alzheimer’s.

The longer the gene"APOE4" The strongest risk factor for developing the disease, although heredity does not mean that a person will definitely develop the condition.

Professor Anne-Marie Minihan, of the University School of Medicine, said: "East Anglia: "We know that 25 percent of women in the UK carry the APOE4 gene and that nearly two-thirds Alzheimer’s patients of women".

added: "The reason for the higher female prevalence rates is thought to be related to the effects of menopause, and the influence of the genetic risk factor APOE4, which is greater in women".

And completed: "We wanted to know if treatment Hormone replacement can prevent cognitive decline in high-risk APOE4 carriers".

The results of the experts showed that carriers of the gene APOE4 who used Hormone replacement therapy They have better perception and higher brain volumes than those who do not use it.

“>

According to the British “Sky News” network, the researchers said that Hormone therapy Alternative, or better known as HRT, is associated with better memory and cognitive function and larger brain size later in life in women who carry a gene considered to be the strongest risk factor for the disease. Alzheimer’s.

The gene isAPOE4It is the strongest risk factor for developing the disease, although heredity does not mean that a person will definitely develop the condition.

Professor Anne-Marie Minihan, from the University of East Anglia Medical School, said: “We know that 25 per cent of women in the UK carry the APOE4 gene and that nearly two-thirds of women carry the APOE4 gene. Alzheimer’s patients of women.”

She added, “It is believed that the reason behind the high prevalence rates of the disease among females is related to the effects of menopause, and the influence of the genetic risk factor APOE4, which is greater in women.”

She added, “We wanted to know if treatment Hormone replacement therapy can prevent cognitive decline in high-risk APOE4 carriers.

The results of the experts showed that carriers of the gene APOE4 who used Hormone replacement therapy They have better perception and higher brain volumes than those who do not use it.

Share:

Facebook
Twitter
Pinterest
LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.